A new cancer-detecting tool uses tiny circuits made of DNA to identify cancer cells by the molecular signatures on their surface.
Duke University researchers fashioned the simple circuits from interacting strands of synthetic DNA that are tens of thousands of times finer than a human hair.
Unlike the circuits in a computer, these circuits work by attaching to the outside of a cell and analyzing it for proteins found in greater numbers on some cell types than others. If a circuit finds its targets, it labels the cell with a tiny light-up tag.
Because the devices distinguish cell types with higher specificity than previous methods, the researchers hope their work might improve diagnosis, and give cancer therapies better aim.
A team led by Duke computer scientist John Reif and his former Ph.D. student Tianqi Song described their approach in a recent issue of the Journal of the American Chemical Society.
Similar techniques have been used previously to detect cancer, but they’re more prone to false alarms — misidentifications that occur when mixtures of cells sport one or more of the proteins a DNA circuit is designed to screen for, but no single cell type has them all.
For every cancer cell that is correctly detected using current methods, some fraction of healthy cells also get mislabeled as possibly cancerous when they’re not.
Each type of cancer cell has a characteristic set of cell membrane proteins on its cell surface. To cut down on cases of mistaken identity, the Duke team designed a DNA circuit that must latch onto that specific combination of proteins on the same cell to work.
As a result they’re much less likely to flag the wrong cells, Reif said.
The technology could be used as a screening tool to help rule out cancer, which could mean fewer unnecessary follow-ups, or to develop more targeted cancer treatments with fewer side effects.
Each basic element of their DNA circuit consists of two DNA strands. The first DNA strand folds over and partially pairs up with itself to form a hairpin shape. One end of each hairpin is bound to a second strand of DNA that acts as a lock and tether, folding in such a way to fit a specific cell surface protein like a puzzle piece. Together these two strands act to verify that that particular protein is present on the cell surface.
To look for cancer, the circuit components are mixed with a person’s cells in the lab. If any cells are studded with the right combination of proteins, the complete circuit will attach. Adding a strand of “initiator” DNA then causes one of the hairpins to open, which in turn triggers another in a chain reaction until the last hairpin in the circuit is opened and the cell lights up.
Test runs of the device in test tubes in Reif’s lab showed it can be used to detect leukemia cells and to distinguish them from other types of cancer within a matter of hours, just by the strength of their glow.
The devices can be easily reconfigured to detect different cell surface proteins by replacing the tether strands, the researchers say. In the future, Reif plans to expand the device to release a small molecule that alerts the body’s immune system to attack the cancer cell.
The technology isn’t ready for prime time yet. The researchers say their DNA circuits require testing in more realistic conditions to make sure they still flag the right cells.
But it’s a promising step toward ensuring that cancer screens and therapies zero in on the right culprits.
Learn more: I.D. VERIFICATION, NOW FOR CANCER
The Latest Google Headlines on:
The Latest Bing News on:
- Swift Biosciences Innovates Swift 2S® Sonic DNA Library Kit for a Rapid, Cost-Effective Workflowon October 7, 2020 at 9:18 am
Oct. 7, 2020 /PRNewswire/ -- Swift Biosciences, Inc., a leader in the commercialization of DNA and RNA Library Preparation ... automated solutions. This new technology minimizes sample handling ...
- Intel’s Commitment to Gaming + Sneak Peek at Intel Technology to Comeon October 7, 2020 at 9:16 am
PC gaming is becoming bigger, more equitable and more diverse, while the quality of today’s hardware and software is expanding. So, it should come as no surprise that Intel is excited to lead the pack ...
- Researchers who can change DNA of animals win Nobel Prizeon October 7, 2020 at 6:20 am
French researcher Emmanuelle Charpentier and U.S researcher Jennifer A. Doudna have been awarded the Nobel Prize in Chemistry.
- Counting the species: how DNA barcoding is rewriting the book of lifeon October 7, 2020 at 4:46 am
Guanacaste conservation area in north-west Costa Rica is the most DNA barcoded place on Earth. On its western frontier, jaguars hunt turtles from the mangrove swamps that line the Pacific coast.
- New DNA test leads to charges in teen rape case from 17 years agoon October 6, 2020 at 11:59 am
Charges were filed in Cedar City on Tuesday against a Utah man accused of raping a 13-year-old girl 17 years ago.
- 'Dipstick' technology could be used for mobile and accurate COVID-19 testingon October 6, 2020 at 7:30 am
Technology that helps to quickly extract and analyze genetic material could be used for cheap, accurate and mobile COVID-19 testing, including at airports and remote testing centres.
- Researchers Extract DNA from Resin-Embedded Insectson October 5, 2020 at 6:31 am
An international team has now detected DNA from ambrosia beetles that were trapped in recent tree resin for less than seven years ...
- Wellcome Sanger Institute Selects Arima Genomics as HiC Technology Partner; Company Announces Early Access Program for high-coverage HiCon October 5, 2020 at 5:05 am
Arima Genomics announces Early Access Program for high-coverage HiC for improved genome assembly after thorough evaluation by Key Opinion Leaders ...
- OriCiro Launches World's First Cell-Free Amplification Technology for Large Circular DNAon September 30, 2020 at 6:43 am
OriCiro Genomics, a pioneer in the cell-free synthesis and amplification of genome-scale large DNA for gene therapy and synthetic biology, has today launched the OriCiroTM Cell-Free Cloning System, ...
- Global Cell-Free DNA Testing Market Phenomenal Growth Prospects, Opportunities, SWOT Study and Volume| Agilent Technology, Allenex, Biocepton September 30, 2020 at 4:48 am
The latest research report provides a complete assessment of the Global Cell-Free DNA Testing market for the forecast year 2020-2029, which is beneficial for companies regardless of their size and ...
The Latest Google Headlines on:
Targeted cancer treatments
The Latest Bing News on:
Targeted cancer treatments
- Biology: Advanced prostate cancer has an unexpected weakness that can be targeted by drugson October 7, 2020 at 7:42 am
SUCLA2 gene is frequently involved in the deletion of RB1 gene region, which occurs in 10 – 30 % of advanced prostate cancers. SUCLA2 deletion gives rise to a metabolic… view more Credit Image: ...
- Advanced prostate cancer has an unexpected weakness that can be targeted by drugson October 7, 2020 at 7:36 am
The compound thymoquinone (TQ) selectively kills prostate cancer cells at advanced stages, according to a new study published in Oncogene. Led by researchers at Kanazawa University, the study reports ...
- Jaguar Health's Napo Pharma initiates crofelemer study in cancer therapy‑related diarrheaon October 7, 2020 at 6:25 am
Jaguar Health's (JAGX +5.8%) subsidiary, Napo Pharmaceuticals, has initiated its Phase 3 trial of crofelemer (Mytesi) for prophylaxis of diarrhea in cancer therapy‑related diarrhea.The 24-week study ...
- GenesisCare Acquires Ten New ExacTrac Dynamic Systems for Advanced Cancer Treatment Following FDA Clearanceon October 7, 2020 at 4:06 am
Brainlab to deliver 10 systems to GenesisCare in the US bringing total investment by the international oncology provider to over 30 systems globally.
- The Future of Breast Cancer Care is Hereon October 6, 2020 at 3:30 pm
One of your neighbors posted in Health & Fitness. Click through to read what they have to say. (The views expressed in this post are the author’s own.) ...
- Terminally ill toddler with brain tumour gains extra time with family thanks to new cancer treatmenton October 5, 2020 at 9:30 pm
They were then able to match the cancer's genetic code with a new targeted drug treatment which worked for Stella. "We were able to live a normal life," Ms Dizon-Bawalan said. "Spending birthdays, ...
- Nuclear magnetic resonance insights set stage for next-gen targeted cancer therapies for adults and childrenon October 2, 2020 at 4:14 am
Scientists at St. Jude Children's Research Hospital have visualized previously unknown structures of the ABL kinase, offering insight for designing the next generation of targeted therapies for adult ...
- PARP Inhibitors Demonstrate the Value of Targeted Treatments in Prostate Canceron October 1, 2020 at 11:18 am
Primed to knock out cells vulnerable due to DNA-repair problems, PARP inhibitors are ushering in a targeted-drug era in prostate cancer treatment.
- Lantheus Holdings Submits New Drug Application to the U.S. FDA for PyL™ (18F-DCFPyL), a PSMA-Targeted Prostate Cancer Imaging Agenton September 30, 2020 at 6:00 am
Lantheus Holdings, Inc., the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of ...
- Global Small Molecule Targeted Cancer Therapy Market To Show Startling Growth During Forecast Period 2020–2026 - Zion Market Researchon September 29, 2020 at 4:00 am
Zion Market Research Reports added Latest Research Report titled Global Small Molecule Targeted Cancer Therapy Market To Show Startling Growth During Forecast Period 2020 2026 Zion Market Research to ...